RT Journal Article
SR Electronic
T1 Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective
JF Journal of Clinical Pathology
JO J Clin Pathol
FD BMJ Publishing Group Ltd and Association of Clinical Pathologists
SP 443
OP 447
DO 10.1136/jclinpath-2020-206854
VO 74
IS 7
A1 Lisa Browning
A1 Richard Colling
A1 Emad Rakha
A1 Nasir Rajpoot
A1 Jens Rittscher
A1 Jacqueline A James
A1 Manuel Salto-Tellez
A1 David R J Snead
A1 Clare Verrill
YR 2021
UL http://jcp.bmj.com/content/74/7/443.abstract
AB The measures to control the COVID-19 outbreak will likely remain a feature of our working lives until a suitable vaccine or treatment is found. The pandemic has had a substantial impact on clinical services, including cancer pathways. Pathologists are working remotely in many circumstances to protect themselves, colleagues, family members and the delivery of clinical services. The effects of COVID-19 on research and clinical trials have also been significant with changes to protocols, suspensions of studies and redeployment of resources to COVID-19. In this article, we explore the specific impact of COVID-19 on clinical and academic pathology and explore how digital pathology and artificial intelligence can play a key role to safeguarding clinical services and pathology-based research in the current climate and in the future.